244 related articles for article (PubMed ID: 9343161)
1. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.
Boomer S; Eiden M; Burns CC; Overbaugh J
J Virol; 1997 Nov; 71(11):8116-23. PubMed ID: 9343161
[TBL] [Abstract][Full Text] [Related]
2. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
Tailor CS; Kabat D
J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
[TBL] [Abstract][Full Text] [Related]
3. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2.
Sugai J; Eiden M; Anderson MM; Van Hoeven N; Meiering CD; Overbaugh J
J Virol; 2001 Aug; 75(15):6841-9. PubMed ID: 11435563
[TBL] [Abstract][Full Text] [Related]
4. Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses.
Anderson MM; Lauring AS; Robertson S; Dirks C; Overbaugh J
J Virol; 2001 Nov; 75(22):10563-72. PubMed ID: 11602698
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive approach to mapping the interacting surfaces of murine amphotropic and feline subgroup B leukemia viruses with their cell surface receptors.
Tailor CS; Nouri A; Kabat D
J Virol; 2000 Jan; 74(1):237-44. PubMed ID: 10590111
[TBL] [Abstract][Full Text] [Related]
6. A 13-amino-acid Pit1-specific loop 4 sequence confers feline leukemia virus subgroup B receptor function upon Pit2.
Dreyer K; Pedersen FS; Pedersen L
J Virol; 2000 Mar; 74(6):2926-9. PubMed ID: 10684313
[TBL] [Abstract][Full Text] [Related]
7. Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants.
Lauring AS; Anderson MM; Overbaugh J
J Virol; 2001 Oct; 75(19):8888-98. PubMed ID: 11533152
[TBL] [Abstract][Full Text] [Related]
8. Genetic and biochemical analyses of receptor and cofactor determinants for T-cell-tropic feline leukemia virus infection.
Lauring AS; Cheng HH; Eiden MV; Overbaugh J
J Virol; 2002 Aug; 76(16):8069-78. PubMed ID: 12134012
[TBL] [Abstract][Full Text] [Related]
9. Fusion-defective gibbon ape leukemia virus vectors can be rescued by homologous but not heterologous soluble envelope proteins.
Farrell KB; Ting YT; Eiden MV
J Virol; 2002 May; 76(9):4267-74. PubMed ID: 11932392
[TBL] [Abstract][Full Text] [Related]
10. Feline leukemia virus infection requires a post-receptor binding envelope-dependent cellular component.
Hussain N; Thickett KR; Na H; Leung C; Tailor CS
J Virol; 2011 Dec; 85(23):12529-36. PubMed ID: 21917946
[TBL] [Abstract][Full Text] [Related]
11. Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant.
Miyake A; Kawasaki J; Ngo H; Makundi I; Muto Y; Khan AH; Smith DJ; Nishigaki K
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996094
[TBL] [Abstract][Full Text] [Related]
12. The receptor binding site of feline leukemia virus surface glycoprotein is distinct from the site involved in virus neutralization.
Ramsey IK; Spibey N; Jarrett O
J Virol; 1998 Apr; 72(4):3268-77. PubMed ID: 9525654
[TBL] [Abstract][Full Text] [Related]
13. Distinctive receptor binding properties of the surface glycoprotein of a natural feline leukemia virus isolate with unusual disease spectrum.
Bolin LL; Chandhasin C; Lobelle-Rich PA; Albritton LM; Levy LS
Retrovirology; 2011 May; 8():35. PubMed ID: 21569491
[TBL] [Abstract][Full Text] [Related]
14. The surface glycoprotein of a natural feline leukemia virus subgroup A variant, FeLV-945, as a determinant of disease outcome.
Bolin LL; Ahmad S; Levy LS
Vet Immunol Immunopathol; 2011 Oct; 143(3-4):221-6. PubMed ID: 21764142
[TBL] [Abstract][Full Text] [Related]
15. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains.
Gwynn SR; Hankenson FC; Lauring AS; Rohn JL; Overbaugh J
J Virol; 2000 Jul; 74(13):5754-61. PubMed ID: 10846053
[TBL] [Abstract][Full Text] [Related]
16. Chimeras of receptors for gibbon ape leukemia virus/feline leukemia virus B and amphotropic murine leukemia virus reveal different modes of receptor recognition by retrovirus.
Pedersen L; Johann SV; van Zeijl M; Pedersen FS; O'Hara B
J Virol; 1995 Apr; 69(4):2401-5. PubMed ID: 7884886
[TBL] [Abstract][Full Text] [Related]
17. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
Chandhasin C; Coan PN; Levy LS
J Virol; 2005 Feb; 79(3):1351-60. PubMed ID: 15650161
[TBL] [Abstract][Full Text] [Related]
18. Cellular and species resistance to murine amphotropic, gibbon ape, and feline subgroup C leukemia viruses is strongly influenced by receptor expression levels and by receptor masking mechanisms.
Tailor CS; Nouri A; Kabat D
J Virol; 2000 Oct; 74(20):9797-801. PubMed ID: 11000257
[TBL] [Abstract][Full Text] [Related]
19. The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors.
Moser M; Burns CC; Boomer S; Overbaugh J
Virology; 1998 Mar; 242(2):366-77. PubMed ID: 9514965
[TBL] [Abstract][Full Text] [Related]
20. Abnormal processing of a recombinant feline leukemia virus envelope polyprotein and its interference with subgroup C virus infection.
Bechtel MK; Stallcup MR; Bedgood RM; Corey JL; Pandey R; Roy-Burman P
Virology; 1994 Jul; 202(1):329-38. PubMed ID: 8009844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
